$CGNX
COGNEX CORP Stock $cgnx

$cgnx Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000085120523000020 Filed on October 31, 2023

Income Statement

Concept	2023 Q4	2022 Q4
Revenue	$197.2M	$209.6M
YoY Change	-5.91%	-26.41%
Cost Of Revenue	$54.47M	$57.38M
YoY Change	-5.08%	-33.05%
Gross Profit	$142.8M	$152.2M
YoY Change	-6.22%	-23.55%
Gross Profit Margin	72.39%	72.63%
Selling, General & Admin	$82.31M	$75.37M
YoY Change	9.2%	-2.26%
% of Gross Profit	57.65%	49.51%
Research & Development	$32.58M	$33.95M
YoY Change	-4.05%	-1.51%
% of Gross Profit	22.82%	22.3%
Depreciation & Amortization	$5.100M	$4.868M
YoY Change	4.77%	-3.62%
% of Gross Profit	3.57%	3.2%
Operating Expenses	$114.9M	$109.3M
YoY Change	5.09%	-2.03%
Operating Profit	$30.64M	$40.02M
YoY Change	-23.45%	-54.28%
Interest Expense	-$3.800M	-$464.0K
YoY Change	718.97%	-139.93%
% of Operating Profit	-12.4%	-1.16%
Other Income/Expense, Net	$173.0K	-$214.0K
YoY Change	-180.84%	71.2%
Pretax Income	$27.00M	$39.35M
YoY Change	-31.37%	-55.58%
Income Tax	$8.086M	$5.365M
% Of Pretax Income	29.95%	13.64%
Net Earnings	$18.92M	$33.98M
YoY Change	-44.33%	-56.93%
Net Earnings / Revenue	9.59%	16.21%
Basic Earnings Per Share	$0.11	$0.20
Diluted Earnings Per Share	$0.11	$0.19
COMMON SHARES
Basic Shares Outstanding	172.2M shares	173.3M shares
Diluted Shares Outstanding	173.4M shares	174.3M shares

Balance Sheet

Concept	2023 Q4	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$512.6M	$474.4M
YoY Change	8.05%	46.6%
Cash & Equivalents	$395.5M	$266.0M
Short-Term Investments	$117.1M	$208.4M
Other Short-Term Assets	$64.30M	$103.0M
YoY Change	-37.59%	78.52%
Inventory	$133.9M	$108.6M
Prepaid Expenses
Receivables	$130.5M	$96.29M
Other Receivables	$4.100M	$3.011M
Total Short-Term Assets	$847.0M	$787.5M
YoY Change	7.56%	23.08%
LONG-TERM ASSETS
Property, Plant & Equipment	$82.97M	$79.43M
YoY Change	4.46%	2.42%
Goodwill	$241.0M	$237.5M
YoY Change	1.49%	-1.74%
Intangibles	$113.0M	$12.41M
YoY Change	809.88%	4.42%
Long-Term Investments	$333.0M	$343.2M
YoY Change	-2.97%	-42.11%
Other Assets	$6.151M	$6.567M
YoY Change	-6.33%	-9.32%
Total Long-Term Assets	$1.143B	$1.113B
YoY Change	2.71%	-18.41%
TOTAL ASSETS
Total Short-Term Assets	$847.0M	$787.5M
Total Long-Term Assets	$1.143B	$1.113B
Total Assets	$1.990B	$1.900B
YoY Change	4.72%	-5.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$23.05M	$22.22M
YoY Change	3.75%	-49.56%
Accrued Expenses	$79.12M	$64.12M
YoY Change	23.4%	-30.64%
Deferred Revenue	$40.25M	$54.78M
YoY Change	-26.53%	53.25%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$169.7M	$161.3M
YoY Change	5.22%	-14.48%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$0.00	$19.32M
YoY Change	-100.0%	24.81%
Total Long-Term Liabilities	$0.00	$19.32M
YoY Change	-100.0%	24.81%
TOTAL LIABILITIES
Total Short-Term Liabilities	$169.7M	$161.3M
Total Long-Term Liabilities	$0.00	$19.32M
Total Liabilities	$501.3M	$511.0M
YoY Change	-1.9%	-10.91%
SHAREHOLDERS EQUITY
Retained Earnings	$534.3M	$510.9M
YoY Change	4.59%	-9.24%
Common Stock	$1.024B	$960.4M
YoY Change	6.61%	4.99%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.489B	$1.389B
YoY Change
Total Liabilities & Shareholders Equity	$1.990B	$1.900B
YoY Change	4.72%	-5.16%

Cashflow Statement

Concept	2023 Q4	2022 Q4
OPERATING ACTIVITIES
Net Income	$18.92M	$33.98M
YoY Change	-44.33%	-56.93%
Depreciation, Depletion And Amortization	$5.100M	$4.868M
YoY Change	4.77%	-3.62%
Cash From Operating Activities	$41.00M	$83.52M
YoY Change	-50.91%	30.23%
INVESTING ACTIVITIES
Capital Expenditures	$5.900M	-$4.352M
YoY Change	-235.57%	5.15%
Acquisitions
YoY Change
Other Investing Activities	$206.1M	$51.27M
YoY Change	302.02%	-203.87%
Cash From Investing Activities	$200.3M	$46.91M
YoY Change	326.95%	-187.7%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-21.90M	-35.52M
YoY Change	-38.35%	52.26%
NET CHANGE
Cash From Operating Activities	41.00M	83.52M
Cash From Investing Activities	200.3M	46.91M
Cash From Financing Activities	-21.90M	-35.52M
Net Change In Cash	219.4M	94.91M
YoY Change	131.16%	-847.68%
FREE CASH FLOW
Cash From Operating Activities	$41.00M	$83.52M
Capital Expenditures	$5.900M	-$4.352M
Free Cash Flow	$35.10M	$87.87M
YoY Change	-60.06%	28.71%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	211768000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	122511000	usd
	cgnx	Proceeds Payments Issuance Of Shares Share Based Payment Arrangement Including Option Exercised Net ProceedsPaymentsIssuanceOfSharesShareBasedPaymentArrangementIncludingOptionExercisedNet	3276000	usd
	cgnx	Proceeds Payments Issuance Of Shares Share Based Payment Arrangement Including Option Exercised Net ProceedsPaymentsIssuanceOfSharesShareBasedPaymentArrangementIncludingOptionExercisedNet	4225000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-207999000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-3493000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-11818000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	214127000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	79843000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	181374000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	186161000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	1480463000	usd
CY2023Q4	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	622000	usd
	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Period Increase Decrease DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease	0	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	109000	usd
	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	133000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	-79000	usd
	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	-733000	usd
CY2023Q4	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	1971000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	41518000	usd
	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	2198000	usd
	cgnx	Non Cash Loss From Catastrophes NonCashLossFromCatastrophes	0	usd
	cgnx	Non Cash Loss From Catastrophes NonCashLossFromCatastrophes	45827000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	59640000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	178387000	usd
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	36209000	usd
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	33837000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-92573000	usd
CY2023Q4	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	10478000	usd
CY2023Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	12365000	usd
CY2023Q4	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.070
CY2023Q4	us-gaap	Dividends Cash DividendsCash	12049000	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	18916000	usd
CY2023Q4	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	707000	usd
CY2023Q4	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	738000	usd
CY2023Q4	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	-624000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	5857000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	255965000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	13905000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	448368000	usd
CY2023Q4	us-gaap	Cash Cash	153785000	usd
CY2022Q4	us-gaap	Cash Cash	180959000	usd
CY2023Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	241716000	usd
CY2022Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	415000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	395501000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	181374000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	117147000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	218759000	usd
CY2023Q4	us-gaap	Long Term Investments LongTermInvestments	332991000	usd
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	454117000	usd
CY2023Q4	cgnx	Cash Cash Equivalents Short Term And Long Term Investments CashCashEquivalentsShortTermAndLongTermInvestments	845639000	usd
CY2022Q4	cgnx	Cash Cash Equivalents Short Term And Long Term Investments CashCashEquivalentsShortTermAndLongTermInvestments	854250000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	469891000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	9000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	19762000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	450138000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	192403000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	19762000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	0	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	0	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Period Increase Decrease DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease	0	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Period Increase Decrease DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease	0	usd
	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Period Increase Decrease DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease	0	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	0	usd
	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	109000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	-733000	usd
	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	-236000	usd
CY2023Q4	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-624000	usd
CY2022Q4	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-79000	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-624000	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-103000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	117147000	usd
CY2023Q4	cgnx	Available For Sale Securities Debt Maturities After One Year Before Two Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneYearBeforeTwoYearsFairValue	113525000	usd
CY2023Q4	cgnx	Available For Sale Securities Debt Maturities After Two Years Before Three Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTwoYearsBeforeThreeYearsFairValue	91970000	usd
CY2023Q4	cgnx	Available For Sale Securities Debt Maturities After Three Years Before Four Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterThreeYearsBeforeFourYearsFairValue	60698000	usd
CY2023Q4	cgnx	Available For Sale Securities Debt Maturities After Four Years Before Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFourYearsBeforeFiveYearsFairValue	59660000	usd
CY2023Q4	cgnx	Available For Sale Securities Debt Maturities After Five Years AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYears	7138000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	450138000	usd
CY2023Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	80091000	usd
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	71720000	usd
CY2023Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1712000	usd
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	906000	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	52063000	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	49854000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	133866000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	122480000	usd
CY2023Q4	us-gaap	Operating Lease Cost OperatingLeaseCost	5512000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	8151000	usd
CY2023Q4	us-gaap	Operating Lease Payments OperatingLeasePayments	5168000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	7532000	usd
CY2023Q4	us-gaap	Lease Cost LeaseCost	132000	usd
	us-gaap	Lease Cost LeaseCost	292000	usd
CY2022Q4	us-gaap	Operating Lease Cost OperatingLeaseCost	2255000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	6699000	usd
CY2022Q4	us-gaap	Operating Lease Payments OperatingLeasePayments	2161000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	6467000	usd
CY2022Q4	us-gaap	Lease Cost LeaseCost	35000	usd
	us-gaap	Lease Cost LeaseCost	110000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	2510000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	11580000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	9677000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	7799000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	7231000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	6992000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	46421000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	92210000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	68432000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	39752000	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.054
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.033
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P10Y9M18D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y9M18D
CY2022Q4	us-gaap	Goodwill Goodwill	242630000	usd
	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-1588000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	241042000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	34195000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	24209000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	9986000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	34195000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	21781000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	12414000	usd
CY2022Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	4375000	usd
	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	1722000	usd
	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	2292000	usd
CY2023Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	3805000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.027
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.040
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.021
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0057
CY2023Q4	us-gaap	Purchase Commitment Remaining Minimum Amount Committed PurchaseCommitmentRemainingMinimumAmountCommitted	70635000	usd
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	196000	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	27000	usd
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	128000	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	479000	usd
CY2023Q4	us-gaap	Derivative Asset Collateral Obligation To Return Cash Offset DerivativeAssetCollateralObligationToReturnCashOffset	0	usd
CY2022Q4	us-gaap	Derivative Asset Collateral Obligation To Return Cash Offset DerivativeAssetCollateralObligationToReturnCashOffset	0	usd
CY2023Q4	us-gaap	Derivative Liability Collateral Right To Reclaim Cash Offset DerivativeLiabilityCollateralRightToReclaimCashOffset	0	usd
CY2022Q4	us-gaap	Derivative Liability Collateral Right To Reclaim Cash Offset DerivativeLiabilityCollateralRightToReclaimCashOffset	0	usd
CY2023Q4	us-gaap	Derivative Assets DerivativeAssets	196000	usd
CY2022Q4	us-gaap	Derivative Assets DerivativeAssets	27000	usd
CY2023Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	128000	usd
CY2022Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	479000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0054
CY2023Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	197241000	usd
CY2022Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	209622000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	640877000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	766657000	usd
CY2023Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	197241000	usd
CY2022Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	209622000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	640877000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	766657000	usd
CY2023Q4	us-gaap	Capitalized Contract Cost Gross CapitalizedContractCostGross	17827000	usd
CY2022Q4	us-gaap	Capitalized Contract Cost Gross CapitalizedContractCostGross	14578000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	730000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	350000	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	500000	usd
	cgnx	Accounts Receivable Allowance For Credit Loss Foreign Exchange Rate Increase Decrease AccountsReceivableAllowanceForCreditLossForeignExchangeRateIncreaseDecrease	0	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	580000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0059
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0044
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.39
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.37
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.39
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.37
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	40787000	usd
	us-gaap	Deferred Revenue Additions DeferredRevenueAdditions	28249000	usd
	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	18809000	usd
	us-gaap	Deferred Revenue Refund Payments1 DeferredRevenueRefundPayments1	9205000	usd
	cgnx	Deferred Revenue Foreign Currency Exchange Adjustment DeferredRevenueForeignCurrencyExchangeAdjustment	-776000	usd
CY2023Q4	us-gaap	Deferred Revenue DeferredRevenue	40246000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8467000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	51.56
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	1395000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	47.49
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	325000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	33.87
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	562000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	57.71
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8975000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	51.19
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y1M17D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	17396000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	5182000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	47.67
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y8M1D
CY2023Q4	cgnx	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableAggregateIntrinsicValue	17378000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	8493000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	51.01
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P5Y11M23D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	17396000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.041
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y10M24D
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y4M24D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y10M24D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y6M
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	20.55
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	18.11
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	18.81
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	21.40
CY2023Q4	cgnx	Shares Based Compensation Arrangement By Shares Based Payment Award Options Exercisable Intrinsic Value SharesBasedCompensationArrangementBySharesBasedPaymentAwardOptionsExercisableIntrinsicValue	557000	usd
	cgnx	Shares Based Compensation Arrangement By Shares Based Payment Award Options Exercisable Intrinsic Value SharesBasedCompensationArrangementBySharesBasedPaymentAwardOptionsExercisableIntrinsicValue	6119000	usd
CY2022Q4	cgnx	Shares Based Compensation Arrangement By Shares Based Payment Award Options Exercisable Intrinsic Value SharesBasedCompensationArrangementBySharesBasedPaymentAwardOptionsExercisableIntrinsicValue	516000	usd
	cgnx	Shares Based Compensation Arrangement By Shares Based Payment Award Options Exercisable Intrinsic Value SharesBasedCompensationArrangementBySharesBasedPaymentAwardOptionsExercisableIntrinsicValue	3615000	usd
CY2023Q4	cgnx	Share Based Compensation Arrangement By Share Based Payment Award Options Vested Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedFairValue	962000	usd
	cgnx	Share Based Compensation Arrangement By Share Based Payment Award Options Vested Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedFairValue	33035000	usd
CY2022Q4	cgnx	Share Based Compensation Arrangement By Share Based Payment Award Options Vested Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedFairValue	1159000	usd
	cgnx	Share Based Compensation Arrangement By Share Based Payment Award Options Vested Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedFairValue	27882000	usd
CY2023Q4	cgnx	Number Of Groups Within Employee Population NumberOfGroupsWithinEmployeePopulation	3	group
CY2023Q4	cgnx	Estimated Forfeiture Rate For Unvested Options For Ceo EstimatedForfeitureRateForUnvestedOptionsForCEO	0
CY2023Q4	cgnx	Estimated Forfeiture Rate For Unvested Options For Senior Management EstimatedForfeitureRateForUnvestedOptionsForSeniorManagement	0.08
CY2023Q4	cgnx	Estimated Forfeiture Rate For Unvested Options For All Non Senior Management EstimatedForfeitureRateForUnvestedOptionsForAllNonSeniorManagement	0.13
	cgnx	Decrease In Compensation Expense Due To Revised Estimated Forfeiture Rates DecreaseInCompensationExpenseDueToRevisedEstimatedForfeitureRates	234000	usd
	cgnx	Increase In Compensation Expense Due To Revised Estimated Forfeiture Rates IncreaseInCompensationExpenseDueToRevisedEstimatedForfeitureRates	1536000	usd
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	68509000	usd
	cgnx	Employee Service Sharebased Compensation Nonvested Awards Compensation Notyet Recognized Periodfor Recognition EmployeeServiceSharebasedCompensationNonvestedAwardsCompensationNotyetRecognizedPeriodforRecognition	P2Y
CY2023Q4	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	12365000	usd
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	6053000	usd
CY2022Q4	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	13366000	usd
CY2022Q4	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	2133000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	41419000	usd
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	6496000	usd
CY2022Q4	cgnx	Employee Service Share Based Compensation Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationRecognizedPeriodCostsCapitalizedAmount	0	usd
CY2023Q4	cgnx	Employee Service Share Based Compensation Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationRecognizedPeriodCostsCapitalizedAmount	0	usd
CY2023Q4	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	12365000	usd
CY2022Q4	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	13366000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	41518000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	41419000	usd
CY2023Q4	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.30
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.16
CY2022Q4	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.14
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.16
CY2023Q4	cgnx	Effective Income Tax Rate Reconciliation Discrete Tax Expense Benefit Amount EffectiveIncomeTaxRateReconciliationDiscreteTaxExpenseBenefitAmount	4035000	usd
	cgnx	Effective Income Tax Rate Reconciliation Discrete Tax Expense Benefit Amount EffectiveIncomeTaxRateReconciliationDiscreteTaxExpenseBenefitAmount	-840000	usd
CY2022Q4	cgnx	Effective Income Tax Rate Reconciliation Discrete Tax Expense Benefit Amount EffectiveIncomeTaxRateReconciliationDiscreteTaxExpenseBenefitAmount	-2000	usd
	cgnx	Effective Income Tax Rate Reconciliation Discrete Tax Expense Benefit Amount EffectiveIncomeTaxRateReconciliationDiscreteTaxExpenseBenefitAmount	3984000	usd
	us-gaap	Income Tax Reconciliation Tax Settlements IncomeTaxReconciliationTaxSettlements	3043000	usd
	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	2178000	usd
	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	2134000	usd
	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	1769000	usd
	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	3822000	usd
	us-gaap	Income Tax Reconciliation Tax Settlements IncomeTaxReconciliationTaxSettlements	2461000	usd
	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	2316000	usd
	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	307000	usd
CY2023Q4	cgnx	Liability For Uncertain Tax Positions LiabilityForUncertainTaxPositions	19450000	usd
	cgnx	Tax Years Open To Examination By Internal Revenue Service TaxYearsOpenToExaminationByInternalRevenueService	2019 through 2022
	cgnx	Income Tax Examination Years Under Examination Other Entities IncomeTaxExaminationYearsUnderExaminationOtherEntities	2017 through 2022
CY2023Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	172169000	shares
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	173256000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	172408000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	173640000	shares
CY2023Q4	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1185000	shares
CY2022Q4	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1071000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1251000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1593000	shares
CY2023Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	173354000	shares
CY2022Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	174327000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	173659000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	175233000	shares
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0000851205-23-000020-index-headers.html	Edgar Link	pending
0000851205-23-000020-index.html	Edgar Link	pending
0000851205-23-000020.txt	Edgar Link	pending
0000851205-23-000020-xbrl.zip	Edgar Link	pending
a1012023-10qxexhibit311.htm	Edgar Link	pending
a1012023-10qxexhibit312.htm	Edgar Link	pending
a1012023-10qxexhibit321.htm	Edgar Link	pending
a1012023-10qxexhibit322.htm	Edgar Link	pending
cgnx-20231001.htm	Edgar Link	pending
cgnx-20231001.xsd	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
cgnx-20231001_htm.xml	Edgar Link	completed
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
cgnx-20231001_cal.xml	Edgar Link	unprocessable
cgnx-20231001_def.xml	Edgar Link	unprocessable
cgnx-20231001_lab.xml	Edgar Link	unprocessable
cgnx-20231001_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CGNX
COGNEX CORP Stock $cgnx

2023 Q4 Form 10-Q Financial Statement

#000085120523000020 Filed on October 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CGNX COGNEX CORP Stock $cgnx

2023 Q4 Form 10-Q Financial Statement

#000085120523000020 Filed on October 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CGNX
COGNEX CORP Stock $cgnx